Active Ingredient History

  • Now
Ziprasidone is atypical antipsychotic, approved by the U.S. Food and Drug Administration for the treatment of schizophrenia, and acute mania and mixed states associated with bipolar disorder. Intramuscilar injections of Ziprasidone are indicated for rapid control of the agitation in schizophrenic patients. Ziprasidone is used off-label for treatment of major depressive disorder, anxiety, obsessive compulsive disorder, borderline personality disorder. Ziprasidone functions as an antagonist at the D2, 5HT2A, and 5HT1D receptors, and as an agonist at the 5HT1A receptor.   NCATS

More Chemistry

Drug Pricing (per unit)

United States

$0.3011 - $49.4050


$0.5763 - $2.3038
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

5-(2-(4-(3-benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one | cp 88059 | cp-88059 | cp-88,059 | cp 88059-01 | cp-88,059-01 | cp-880591 | cp-88,059-1 | cp-88059-1 | cp-8805927 | cp-88059-27 | geodon | zaprasidone | zeldox | ziprasidona | ziprasidone | ziprasidone hcl | ziprasidone hydrochloride | ziprasidone hydrochloride, monohydrate | ziprasidone mesilate | ziprasidone mesylate | ziprasidonum | ziprazidone


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue